Galectin Therapeutics Reports 2017 Second Quarter Financial Results and Provides Business Update

Go back to Galectin Therapeutics Reports 2017 Second Quarter Financial Results and Provides Business Update
GALECTIN (NASDAQ: GALT) Delayed: 3.71 +0.03 (0.82%)
Previous Close $3.68    52 Week High $3.05 
Open $3.73    52 Week Low $0.49 
Day High $3.79    P/E N/A 
Day Low $3.69    EPS $-1.32 
Volume 171,131